Abemaciclib is a potent inhibitor of DYRK1A and HIP kinases involved in transcriptional regulation.
Nature communications
View this publicationNature communications
View this publicationMolecular psychiatry
View this publicationPLoS neglected tropical diseases
View this publicationeLife
View this publicationImmunotherapy
View this publicationJournal of hepatology
View this publicationNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
View this publicationCancers
View this publicationBMC gastroenterology
View this publicationNature communications
View this publication